- Childhood MS: A guide for parents
- Queen’s University Belfast Awarded £2M in Bid to Reverse Myelin Damage in MS
- Exploring Multiple Sclerosis from the Inside
- Rare Form of MS Could Be Caused by Single Genetic Mutation
- Gut Bacteria Differs in Multiple Sclerosis Patients
- Antibody Created in Lab Treats MS in Mice by Preventing Immune Cells from Piercing Blood-Brain Barrier
- Nearly 75% of MS Patients in UK Study Went Through Progressive Decline Prior to Death
- Retinal Thickness May Mark Cognitive Decline
- Does spinal trauma trigger Multiple Sclerosis?
- Multiple sclerosis: IVIG reduces postpartum relapse rate
- Autoimmune diseases may be side effect of a strong immune system
- Development of a sensitive outcome for economical drug screening for progressive multiple ..
- Anticoagulants, Multiple Sclerosis Fatigue Studies Receive $5.5M in PCORI Funding
- Guidelines for Neuropsychological Research in Multiple Sclerosis
- Obesity and multiple sclerosis: Is there a causal relationship?
- Scientists want to use parasitic worms to treat multiple sclerosis
- Tracking brain atrophy in MS could become routine, thanks to software developed at UB
- Predictors of Long-Term Disability in Multiple Sclerosis
- 127 Progressive MS Patients Finish Treatment in Phase 2 Study of Ibudilast, MediciNova Reports
- Study of Potential Therapy for Relapsing MS That Targets B-Cells Now Recruiting Patients in US
- Role of IL-17-producing lymphocytes in severity of multiple sclerosis upon natalizumab treatment
- A Phase I Study: Safety of RG2077 (CTLA4-IgG4m)
- Fingolimod (Gilenya) Seen to Promote Peripheral Nerve Regeneration in Mice, Aiding Remyelination
- Disease Modifying Drugs Seen to Help Protect MS Patients with Benign Status from Greater Disability
- Low-Quality Generic MS Drugs Can Be Both Toxic and Ineffective, Study Reports
- Advanced Structural and Functional Brain MRI in Multiple Sclerosis
- Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis
- Ampyra (dalfampridine) Cost, Dosage, and Prescribing Information for Multiple Sclerosis
- Multiple Sclerosis Prognosis and Your Life Expectancy
- Medical marijuana: Does research back up claims of therapeutic benefits?
- FDA Approves Syndros, Marijuana In Liquid Form — But Is It More Effective Than Pills?
- ‘Ireland is behind the times’: Should cannabis be legalised for medical use?
- Is Lemtrada (Alemtuzumab) Chemotherapy?
- Pre-Trigeminal Neuralgia Symptoms: When You Should See a Doctor
- [VIDEO] Symptoms of vitamin D deficiency
- Cancer Risk with Mitoxantrone
Stem Cell Treatment
- Hundreds of U.S. Clinics Sell Unproved Stem Cell Treatments
- Stem Cell Therapies Are Still Mostly Theory, Yet Clinics Are Flourishing
- 5 Things You Probably Don’t Know About Stem Cell Treatments
- 9 Hematopoietic Stem Cell Transplantation (HSCT) Articles You Must Read
- Study That May Benefit MS Patients Awarded Grant from National Stem Cell Foundation
General News, with many thanks to Barts MS Blog
- Mapping the Brain
- ClinicSpeak & BrainHealth: finally a version for MSer
- Studies will give patients evidence to help them choose among therapies
- The Relationship Between MS and Suicide
- Studying How People with Multiple Sclerosis Experience Prognostic Uncertainty
- Depression in Multiple Sclerosis Linked to Brain Inflammation
- 10 Ways to Stop Stress Now
- Mindfulness Meditation: Easing MS Anxiety
- Could Drinking Four Cups of Coffee a Day Help You Fight MS?
- How to eat right for brain health
- Salt intake in multiple sclerosis: friend or foe?
- Diet analysis paper
- Multiple sclerosis patients may improve cognition with regular walking, cycling, and yoga
- Multiple sclerosis: aquatic exercise improves balance, gait
- Systematic, Evidence-Based Review of Exercise, Physical Activity, and Physical Fitness Effects on Cognition in Persons with Multiple Sclerosis
- The Adaptive Yoga Book For People Living With Multiple Sclerosis
- Video Games May Improve Brain Function Of Multiple Sclerosis Patients
- 10 Multiple Sclerosis’ Self-Managing Tips
- Five Tips to Care for a Loved One Diagnosed with Multiple Sclerosis
- Strategies for Keeping Cool with MS in the Summer Heat
- Telemedicine Can Make Life Easier for Multiple Sclerosis Patients
- Talking About Accessible Travel
- The Limits of Google: How Patients Can Find Out What Works In Medical Care
- ‘My MS Manager’ Named One of Best Apps for MS for 4th Year
- Pathmaker Neurosystems named as finalist for the Innovation Prize 2016
- Increasing Disability in MS Matched by Rising Financial, Personal and Work-related Burdens
- A lesser-known multiple-sclerosis issue — money problems
- New seniors study suggests Vitamin D could prevent cognitive decline
- High Doses of Vitamin D Unlikely to Help MS Patients, But Daily Low Dose Good for All, UK Group …
- Multiple Sclerosis Prognosis and Your Life Expectancy
When New Symptoms Visit You
- [VIDEO] Cognitive Fatigue in MS
- Swallowing hard: dysphagia and MS
- Optic Neuritis Commonly Asked Questions
- What is the Difference Between Relapsing and Progressive MS?
- Increased Prevalence of Neurological Disorders to Create Opportunities for the Neurodiagnostic
- Pharma Industry Outlook: Fundamentals Remain Strong
- An Investing Overview of the Multiple Sclerosis MarketInvestor’s Watch List: Ionis Pharmaceuticals, Inc. (IONS), Visteon Corporation (VC), Textron Inc.
- Multiple sclerosis drug pipeline
- Bayer beats expectations in 2nd-qtr results; raises guidance
- Merck KGaA’s Investigational MS Therapy Cladribine Gets EMA Marketing Authorization Application Review
- Merck KGaA’s Multiple Sclerosis Drug under Review in EU
- Avonex (Multiple Sclerosis) Market Research Report Now Available at Research Corridor
- What Are Analysts Saying About Q2 at Biotech’s Big 4? Amgen, Biogen, Celgene, Gilead
- Aubagio Multiple Sclerosis Market Research Report Now Available at Research Corridor
- Sanofi determined to get Medivation as sales slide
- AbbVie Results Boosted by Humira, Pipeline Growth
©Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me, 2011-2016. Unauthorized use and/or duplication of this material without express and written permission from this blog’s author and/or owner are strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me with appropriate and specific direction to the original content.